Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain

被引:60
作者
Bazinet, RP
Lee, HJ
Felder, CC
Porter, AC
Rapoport, SI
Rosenberger, TA
机构
[1] NIA, Brain Physiol & Metab Sect, NIH, Bethesda, MD 20892 USA
[2] Lilly Res Labs, Div Neurosci, Indianapolis, IN 46285 USA
[3] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA
关键词
anandamide; arachidonic acid; brain; decapitation; ischemia; microwave;
D O I
10.1007/s11064-005-2746-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Anandamide (N-arachidonoylethanolamine, AEA) is the putative endogenous ligand for the CB1 receptor. Despite being regulated enzymatically, brain AEA concentrations are quite variable and have been reported to increase in response to ischemia and post-mortem delay. Because these observations are similar to the effects of decapitation on brain concentrations of unesterified arachidonic acid and several of its metabolites, we propose that brain AEA concentrations also increase with decapitation and that immediate head-focused microwave irradiation is necessary to quantify basal brain AEA levels correctly. To test this hypothesis, we measured brain AEA levels in rats that were subjected to head-focused microwave irradiation 5 min. following decapitation (5.5 kW, 3.4 s) ( ischemic) and prior to decapitation ( controls). Brain AEA concentrations were quantified by LC/MS/MS. AEA concentrations from ischemic animals (10.01 +/- 4.41 pmol/g, mean +/- SD) were significantly higher and more variable than control concentrations (2.45 +/- 0.39 pmol/g). Thus, the basal concentration of AEA in the brain is lower than previously thought and future studies attempting to quantify brain AEA should consider using head-focused microwave fixation to prevent anomalous results.
引用
收藏
页码:597 / 601
页数:5
相关论文
共 43 条
  • [1] INVIVO REGIONAL LEVELS OF PGE AND THROMBOXANE IN MOUSE-BRAIN - EFFECT OF DECAPITATION, FOCUSED MICROWAVE FIXATION, AND INDOMETHACIN
    ANTON, RF
    WALLIS, C
    RANDALL, CL
    [J]. PROSTAGLANDINS, 1983, 26 (03): : 421 - 429
  • [2] BACHUR NR, 1965, J BIOL CHEM, V240, P1019
  • [3] BAZAN NG, 1993, PROG BRAIN RES, V96, P247
  • [4] MEDIATORS OF INJURY IN NEUROTRAUMA - INTRACELLULAR SIGNAL-TRANSDUCTION AND GENE-EXPRESSION
    BAZAN, NG
    DETURCO, EBR
    ALLAN, G
    [J]. JOURNAL OF NEUROTRAUMA, 1995, 12 (05) : 791 - 814
  • [6] Massive accumulation of N-acylethanolamines after stroke.: Cell signalling in acute cerebral ischemia?
    Berger, C
    Schmid, PC
    Schabitz, WR
    Wolf, M
    Schwab, S
    Schmid, HHO
    [J]. JOURNAL OF NEUROCHEMISTRY, 2004, 88 (05) : 1159 - 1167
  • [7] Brain regional distribution of endocannabinoids: Implications for their biosynthesis and biological function
    Bisogno, T
    Berrendero, F
    Ambrosino, G
    Cebeira, M
    Ramos, JA
    Fernandez-Ruiz, JJ
    Di Marzo, V
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 256 (02) : 377 - 380
  • [8] CORRELATION BETWEEN RELEASE OF FREE ARACHIDONIC-ACID AND PROSTAGLANDIN FORMATION IN BRAIN CORTEX AND CEREBELLUM
    BOSISIO, E
    GALLI, C
    GALLI, G
    NICOSIA, S
    SPAGNUOLO, C
    TOSI, L
    [J]. PROSTAGLANDINS, 1976, 11 (05): : 773 - 781
  • [9] Evidence for a new G protein-coupled cannabinoid receptor in mouse brain
    Breivogel, CS
    Griffin, G
    Di Marzo, V
    Martin, BR
    [J]. MOLECULAR PHARMACOLOGY, 2001, 60 (01) : 155 - 163
  • [10] Cadas H, 1997, J NEUROSCI, V17, P1226